<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>After <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, significant amounts of <z:chebi fb="3" ids="16335">adenosine</z:chebi> 5'-<z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi> are released or leaked from damaged cells, thus activating purinergic receptors in the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="1" pm="."><plain>A number of P2X/P2Y receptors have been implicated in ischemic conditions, but to date the P2Y(1) receptor (P2Y(1)R) has not been implicated in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we found that the astrocytic P2Y(1)R, via phosphorylated-RelA (p-RelA), has a negative effect during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Intracerebroventricular administration of the P2Y(1)R <z:chebi fb="4" ids="48705">agonist</z:chebi>, MRS 2365, led to an increase in cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume 72 hours after transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of the P2Y(1)R <z:chebi fb="68" ids="48706">antagonist</z:chebi>, MRS 2179, significantly decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and led to recovered motor coordination </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of MRS 2179 occurred within 24 hours of tMCAO, and also markedly reduced the expression of p-RelA and interleukin-6, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α, monocyte chemotactic protein-1/chemokine (C-C motif) ligand 2 (CCL2), and interferon-inducible protein-10/chemokine (C-X-C motif) ligand 10 (CXCL10) <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>P2Y(1)R and p-RelA were colocalized in glial fibrillary acidic protein-positive astrocytes, and an increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after MRS 2365 treatment was inhibited by the nuclear factor (NF)-κB inhibitor <z:chebi fb="28" ids="28938">ammonium</z:chebi> <z:chebi fb="0" ids="33135">pyrrolidine</z:chebi> dithiocarbamate </plain></SENT>
<SENT sid="7" pm="."><plain>These results provide evidence that the P2Y(1)R expressed in cortical astrocytes may help regulate the cytokine/chemokine response after tMCAO/reperfusion through a p-RelA-mediated NF-κB pathway </plain></SENT>
</text></document>